Jordi Muchart López
Investigador
Jordi Muchart López graduated in Medicine in 2001 from the University of Barcelona and obtained his degree in Radiology in 2006.
He joined SJD Barcelona Children's Hospital as an adjunct physician in the Department of Diagnostic Imaging in 2009 where he has developed his research in the field of neuroscience in collaboration with the departments of Neuropediatrics, Neonatology, Genetics, Oncology and Neurosurgery. He is currently a consultant. Part of his research has been carried out in collaboration with CIBERER, the Cognition and Brain Plasticity Unit of IDIBELL - UB, FIDMAG and CREAL-ISGLobal.
Also, he collaborates as a lecturer in the Masters in Neuropediatrics, Child Neuropsychology, Pediatric Endocrinology and Epilepsy at the SJD Barcelona Children's Hospital -Hospital Clínic of the University of Barcelona.
Last Publications
- Tangeraas T, Ribeiro J, Backe PH, De Oyarzabal-Sanz AL, Neugebauer J, Weinhold N, Boemer F, Debray FG, Ozturk-Hism B, Evren G, Tuba EF, Ummuhan O, Footitt E, Davison J, Martinez C, Bueno C, Machado I, Rodríguez-Pombo P, Al-Sannaa N, de los Santos MM, Muchart-Lopez J, Ozturkmen-Akay H, Karaca M, Tekin M, Pajares S, Ormazabal-Herrero A, Stoway SD, Artuch-Iriberri R, Dixon M, Mørkrid L and Garcia-Cazorla A BCKDK deficiency: a treatable neurodevelopmental disease amenable to newborn screening BRAIN . 146(7): 3003-3013.
- Casas-Alba D, Aguilar A, Alonso I, García MT, Cilio MR and Fons-Estupina C Relationship Between Epileptic Activity and Developmental Outcome in KCNQ2-Related Epilepsy PEDIATRIC NEUROLOGY . 144: 11-15.
- Muñoz-Pujol G, Ortigoza-Escobar JD, Paredes-Fuentes AJ, Jou-Munoz C, Ugarteburu O, Gort L, Yubero-Siles D, Garcia-Cazorla A, O'Callaghan-Gordo M, Campistol-Plana J, Muchart-Lopez J, Yépez VA, Gusic M, Gagneur J, Prokisch H, Artuch-Iriberri R, Ribes A, Urreizti R and Tort F Leigh syndrome is the main clinical characteristic of PTCD3 deficiency BRAIN PATHOLOGY . 33(3): .
Projects
- Project name:
- Effectiveness, cost-utility and neurobiological effects of low-dose naltrexone in patients with fibromyalgia (INNOVA project)
- Leader
- Juan Vicente Luciano Devis
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- ICI20/00080
- Starting - finishing date:
- 2021 - 2024
- Project name:
- Sistema de ayuda a la decisión clínica para la evaluación y predicción de enfermedad vascular cerebral pediátrica: Radiómica a partir de RM vascular e Inteligencia Artificial (Vasculómica)
- Leader
- Jose Luis Munuera del Cerro
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI20/00296
- Starting - finishing date:
- 2021 - 2023
- Project name:
- Medicina personalizada en los defectos genéticos de la neurotransmisión en pediatría. Nuevo enfoque basado en el metabolismo de la sinapsis neuronal
- Leader
- MªAngels García Cazorla
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI18/00111
- Starting - finishing date:
- 2019 - 2022